Navigation Links
Align(R) Daily Probiotic Supplement Meets New Consumer Guidelines
Date:2/5/2009

Align with Bifantis(R) meets high standards set by independent scientific association to help consumers choose credible probiotic products

CINCINNATI, Feb. 5 /PRNewswire-FirstCall/ -- According to a new set of guidelines unveiled yesterday by The International Scientific Association for Probiotics and Prebiotics (ISAPP) there are five key criteria that consumers should consider when selecting a probiotic product -- strain specificity, clinical proof, packaging, and the quality and quantity of probiotics in a product. The Procter & Gamble daily probiotic supplement Align, fully meets these criteria, making it a good option for those who want to build and maintain a natural defense against abdominal discomfort and episodic digestive upsets such as bloating, constipation, diarrhea, gas and urgency.*

Titled the "Ps and Qs of Probiotics", these criteria were developed to help consumers select credible, effective probiotic products in a crowded market.

"These new guidelines set a high standard that few probiotic products currently on the market can meet," said Susan Abeln, R.Ph. Principal Scientist, Procter & Gamble Research and Development. "With Align, P&G has been committed to ensuring the highest quality, every step of the way -- from research to manufacturing to packaging. Align already has strong clinical proof behind it, and the fact that Align meets these guidelines is just further proof for why it is recommended by some of the world's leading gastroenterologists."

Below is an outline of how Align meets the "Ps and Qs of Probiotics", which were reviewed and approved by respected researchers across the United States, Canada and Europe.

  • Probiotic Strain: Bifidobacterium infantis 35624 (the unique strain trademarked as Bifantis) is the sole ingredient in Align and belongs to the well-researched Bifidobacterium
    '/>"/>

SOURCE Procter & Gamble
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Dallas Among the First to Offer Probiotic Supplement Align(R)
2. Pharmacy Technician Certification Board (PTCB) Unveils New Testing Features for 2009: PTCB Exam to be Offered Daily; Test Results Given to Candidates Immediately in 2009
3. Surveyed Neurologists in Both the U.S. and Europe Would Welcome an Antiepileptic Drug That is Administered Once-Daily
4. Labopharm to host conference call to discuss FDA approval of once-daily RYZOLT(TM) on Tuesday, January 6, 2009 at 8:30 a.m. (ET)
5. Labopharm Announces FDA Approval of Once-Daily RYZOLT(TM) (Tramadol HCL Extended Release Tablets) for Management of Moderate to Moderately Severe Chronic Pain
6. Brides-To-Be Should Say I Do to a Daily Multivitamin With Folic Acid
7. Womens Health The Daily Fix Your Guide to Healthy Habits for Good Nutrition
8. First and Only Single Capsule Daily Rx Prenatal Vitamin With Plant-Based DHA Now Available
9. European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naive Adults With HIV-1
10. Molecular partnership controls daily rhythms, body metabolism
11. NxStage(R) Achieves Milestone with 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009).... 27 Shamir Optical Indu... provider of innovative products and technology to...its board of directors had declared a dividend dis... (approximately NIS 37.62 million based on the Nov...r approximately US$ 0.609 (approximately NIS 2.3 b...
(Date:11/27/2009)...vehicles may reduce future disease burden, researc...News) -- Encouraging city dwellers to walk and bic...r public health benefits than increased used of lo..., The study compared the projected health effec...narios for London, England, and Delhi, India: bus...
(Date:11/27/2009)...ov. 27 Allrecipes.com , the wor...ng traffic numbers, with more than 2.8 million vis...ar picture of what was served on the biggest food ... in 2009 weighed in at 2,225 calories per serving,...rding to the Allrecipes site, Sweet Potato Pie I ...
(Date:11/27/2009)...e bilingual coloring books designed for children a...unity to educate - inform parents and children ali...Dinosuars to ABC,S and a host of other topics. , ...vember 27, 2009 -- Today’s children have eno... any hour of the day, but one of the oldest and si...
(Date:11/27/2009)...teractive anatomy education apps from Modality and...ciences learning opportunities for iPhone and iPod...s) November 27, 2009 -- Modality, Inc. and Lippi...Wolters Kluwer Health, today announced the availab...pp Store. Clemente’s Anatomy, Rohen’s ...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5
...at the U.S. Department of Energy,s Brookhaven Nati...in level of receptors for dopamine, a pleasure-rel...cent in rats trained to self-administer it. Earlie...ve useful in treating addiction, according to the ...
...16 The Blackstone,Group has today informed us tha... Gerresheimer AG, held by BCP Murano II S.a.r.l. w...tion, led by Credit Suisse, 7.8 million,shares wil...07. Dr. Axel Herberg, CEO of Gerresheimer AG: "Bla...
...ay is National Skin Cancer,Awareness Month. TOPEX,...his disease with a low energy or superficial x-ray...ent procedure. This new system provides,an alterna...sitive structures in the head and neck regions -- ...
...omen with breast cancer have worse disease outcome... first time with more advanced disease, two scient...e (EBCC-6) today (Wednesday 16 April). , Dr. E...howed that women who had a body mass index (BMI) o...
...O2 Plastics, Inc.,(OTC Bulletin Board: ECOO), the ...e way plastics are recycled, today reported its 20.... The Company reported revenues of,$4.3 million fo... $32.6 million in 2007 versus $20.8 million for th...
...ers at the Duke School of Medicine apparently have...so much, and it may be a mechanism that could lead... a graduate student in Assistant Professor Jeffrey...ogrammed cell death. They make use of a protein ca...
Other Medicine News:Health News:Gene therapy reduces cocaine use in rats 2Health News:An Alternative to Surgery for Treating Skin Cancer 2Health News:An Alternative to Surgery for Treating Skin Cancer 3Health News:Obese women disadvantaged in both breast cancer treatment and diagnosis 2Health News:Obese women disadvantaged in both breast cancer treatment and diagnosis 3Health News:ECO2 Plastics, Inc. Reports 2007 Year End Financial Results, Announces FDA Filing and Provides Outlook for 2008 2Health News:ECO2 Plastics, Inc. Reports 2007 Year End Financial Results, Announces FDA Filing and Provides Outlook for 2008 3Health News:A potential sugar fix for tumors 2
(Date:11/25/2009)..., NEW YORK, Nov. 25 Reportlinker...s available in its catalogue: ,, Intranasal Dr...tp://www.reportlinker.com/p0164267/Intranasal-Drug... The US intranasal drug delivery market is witness...the delivery of conventional local therapeutic dru...
(Date:11/25/2009)...NTAIN VIEW, Calif., Nov. 25 Chem...clinical data from the Company,s PROTECT-1 (the Pr...ohn,s disease Trial) of Traficet-EN(TM) (CCX282-B)...se demonstrated clinical efficacy with a favorable...strated evidence of clinical efficacy in the reduc...
(Date:11/24/2009)...VINE, Calif., Nov. 24 En...ally invasive treatments for aortic disorders, ann...r discontinue all proceedings in, the patent infri... by Cook, Inc. The motion was filed in the United..., Endologix has requested that the stay remain ...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 1YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 3BeamOne LLC to Add New Ebeam Sterilization Service Center 6384 1BeamOne LLC to Add New Ebeam Sterilization Service Center 6384 2Residential design for persons with neurological disability 61642 1Residential design for persons with neurological disability 61642 2Residential design for persons with neurological disability 61642 3
...es,Pharmaceuticals, Inc., (Nasdaq: ALSE ), announ...n the initial stage of the ALTROPANE(R) Parkinson,...cal trial program. This,subject was enrolled at th...er the direction of Principal Investigator Dr. Ray...ment of Neurology., ALTROPANE is a diagnostic mol...
...(TM) shows lifesaving potential -, - HGS on trac...ockpile beginning in 2008...s, Inc. (Nasdaq: HGSI ) today announced that the ...e-saving potential of its human,monoclonal antibod... that a,single dose of ABthrax, administered witho...
Other Medicine Technology:Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 2Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 3Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 4Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 5New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 2New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 3New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 4New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 5New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 6New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 7
Lasik Irrigator - 4 ports
Lasik Cannula - Rosen
Anterior Chamber Maintainer
Sub-Tenon's Cannula
Medicine Products: